Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation

NCT00516152 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00516152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00516152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
November 30, 2007
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelogenous leukemia, advanced myeloproliferative disease, chronic myeloid leukemia, lymphoproliferative disease, multiple myeloma, myelodysplasia, non-hodgkin's lymphoma, severe aplastic anemia